BackCitius Oncology Overview
Citius Oncology Inc.

Citius Oncology Discounted Cash Flow

Compare Citius Oncology's DCF valuation ($0.0017) to today's market price.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$0.00

Current Fair Value

$0.00
↓ 99.8% Downside

Overvalued by 99.8% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading

Citius Oncology (CTOR) FAQ

Citius Oncology (CTOR) currently reports a DCF fair value of $0.0017. Use the charts on this page to explore Citius Oncology's DCF fair value history and peer comparisons.

Citius Oncology's discounted cash flow (DCF) fair value estimate is $0.0017, about 99.8% overvalued versus the current market price. DCF models project future free cash flows and discount them back to today — so the result depends on growth, margin, and discount-rate assumptions. Use it as one valuation lens alongside multiples and peer checks on Stockcircle.

Start with the current DCF fair value of $0.0017, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Citius Oncology, and consider following CTOR for alerts when major investors trade the stock.